232 related articles for article (PubMed ID: 10885641)
21. Skating on thin ice: pragmatic prescribing for medication refractory schizophrenia.
Tracy DK; Joyce DW; Sarkar SN; Mateos Fernandez MJ; Shergill SS
BMC Psychiatry; 2015 Jul; 15():174. PubMed ID: 26205327
[TBL] [Abstract][Full Text] [Related]
22. Combination antipsychotics: pros, cons, and questions.
Miller AL; Craig CS
Schizophr Bull; 2002; 28(1):105-9. PubMed ID: 12047009
[TBL] [Abstract][Full Text] [Related]
23. Augmentation strategies in partial responder and/or treatment-resistant schizophrenia patients treated with clozapine.
Muscatello MR; Bruno A; De Fazio P; Segura-Garcia C; Pandolfo G; Zoccali R
Expert Opin Pharmacother; 2014 Nov; 15(16):2329-45. PubMed ID: 25284216
[TBL] [Abstract][Full Text] [Related]
24. Efficacy of adjunctive treatments added to olanzapine or clozapine for weight control in patients with schizophrenia: a systematic review and meta-analysis.
Choi YJ
ScientificWorldJournal; 2015; 2015():970730. PubMed ID: 25664341
[TBL] [Abstract][Full Text] [Related]
25. Efficacy and safety of combining clozapine with electrical or magnetic brain stimulation in treatment-refractory schizophrenia.
Arumugham SS; Thirthalli J; Andrade C
Expert Rev Clin Pharmacol; 2016 Sep; 9(9):1245-52. PubMed ID: 27322602
[TBL] [Abstract][Full Text] [Related]
26. Risperidone augmentation of clozapine: a critical review.
Kontaxakis VP; Ferentinos PP; Havaki-Kontaxaki BJ; Paplos KG; Pappa DA; Christodoulou GN
Eur Arch Psychiatry Clin Neurosci; 2006 Sep; 256(6):350-5. PubMed ID: 16900439
[TBL] [Abstract][Full Text] [Related]
27. Clozapine Augmentation With Antiepileptic Drugs for Treatment-Resistant Schizophrenia: A Meta-Analysis of Randomized Controlled Trials.
Zheng W; Xiang YT; Yang XH; Xiang YQ; de Leon J
J Clin Psychiatry; 2017 May; 78(5):e498-e505. PubMed ID: 28355041
[TBL] [Abstract][Full Text] [Related]
28. Clozapine use in geriatric patients- Challenges.
Mukku SSR; Sivakumar PT; Varghese M
Asian J Psychiatr; 2018 Mar; 33():63-67. PubMed ID: 29529421
[TBL] [Abstract][Full Text] [Related]
29. Mid-term and long-term efficacy and effectiveness of antipsychotic medications for schizophrenia: a data-driven, personalized clinical approach.
Glick ID; Correll CU; Altamura AC; Marder SR; Csernansky JG; Weiden PJ; Leucht S; Davis JM
J Clin Psychiatry; 2011 Dec; 72(12):1616-27. PubMed ID: 22244023
[TBL] [Abstract][Full Text] [Related]
30. Weight Loss During Atomoxetine Add-on to Clozapine-Responsive Schizophrenia.
Naguy A; Alamiri B; Khraibut B
Am J Ther; 2018; 25(6):e774-e775. PubMed ID: 29782344
[No Abstract] [Full Text] [Related]
31. Clozapine induced akathisia: a case report and review of the evidence.
Grover S; Sahoo S
Indian J Pharmacol; 2015; 47(2):234-5. PubMed ID: 25878393
[TBL] [Abstract][Full Text] [Related]
32. NMS after clozapine initiation.
Skarpathiotakis M; Westreich N
J Am Acad Child Adolesc Psychiatry; 2005 Nov; 44(11):1101-2. PubMed ID: 16239854
[No Abstract] [Full Text] [Related]
33. [Effectiveness of antipsychotics in schizophrenia and related disorders. Results of a naturalistic study].
Carpiniello B; Mellino G; Pintore S; Puddu L; Pinna F
Clin Ter; 2011; 162(4):331-41. PubMed ID: 21912821
[TBL] [Abstract][Full Text] [Related]
34. Management of treatment resistant schizophrenia unresponsive to clozapine.
Barnes TR; McEvedy CJ; Nelson HE
Br J Psychiatry Suppl; 1996 Dec; (31):31-40. PubMed ID: 8968653
[No Abstract] [Full Text] [Related]
35. Clozapine and long-acting injectable antipsychotic combination: A retrospective one-year mirror-image study.
Souaiby L; Gauthier C; Rieu C; Krebs MO; Advenier-Iakovlev E; Gaillard R
Schizophr Res; 2017 Oct; 188():89-91. PubMed ID: 28139358
[TBL] [Abstract][Full Text] [Related]
36. When treating patients with schizophrenia, what clinical points should be considered if lamotrigine is chosen to augment clozapine?
Dursun SM; Devarajan S
J Psychiatry Neurosci; 2001 Mar; 26(2):168. PubMed ID: 11496920
[No Abstract] [Full Text] [Related]
37. A Retrospective Investigation of Clozapine Treatment in Autistic and Nonautistic Children and Adolescents in an Inpatient Clinic in Turkey.
Yalcin O; Kaymak G; Erdogan A; Tanidir C; Karacetin G; Kilicoglu AG; Mutlu C; Adaletli H; Gunes H; Bahali K; Ayik B; Uneri OS
J Child Adolesc Psychopharmacol; 2016 Nov; 26(9):815-821. PubMed ID: 26771824
[TBL] [Abstract][Full Text] [Related]
38. Efficacy of pimozide augmentation for clozapine partial responders with schizophrenia.
Gunduz-Bruce H; Oliver S; Gueorguieva R; Forselius-Bielen K; D'Souza DC; Zimolo Z; Tek C; Kaliora S; Ray S; Petrides G
Schizophr Res; 2013 Feb; 143(2-3):344-7. PubMed ID: 23219861
[TBL] [Abstract][Full Text] [Related]
39. Augmentation strategies in clozapine-resistant schizophrenia.
Remington G; Saha A; Chong SA; Shammi C
CNS Drugs; 2005; 19(10):843-72. PubMed ID: 16185094
[TBL] [Abstract][Full Text] [Related]
40. Augmentation with sulpiride for a schizophrenic patient partially responsive to clozapine.
Stubbs JH; Haw CM; Staley CJ; Mountjoy CQ
Acta Psychiatr Scand; 2000 Nov; 102(5):390-3; discussion 393-4. PubMed ID: 11098812
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
